We are live on ! Find out more
ORC

O'Rourke & Company Portfolio holdings

AUM $253M
1-Year Est. Return 16.72%
This Fund
S&P 500
This Quarter Est. Return
-13.66%
1 Year Est. Return
+16.72%
3 Year Est. Return
+62.38%
5 Year Est. Return
10 Year Est. Return
AUM
$118M
AUM Growth
-$27.2M
Cap. Flow
-$6.98M
Cap. Flow %
-5.92%
Top 10 Hldgs %
41.5%
Holding
126
New
4
Increased
39
Reduced
62
Closed
12

Sector Composition

Rank Sector Weight
1 Technology 14.78%
2 Financials 14.41%
3 Healthcare 6.59%
4 Communication Services 4.13%
5 Consumer Discretionary 2.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HEAL
126
Global X Funds Global X HealthTech ETF
HEAL
$29.4M
-5,247
Closed -$228K

Similar funds

O'Rourke & Company's Q2 2022 Portfolio in Review

As of Q2 2022, O'Rourke & Company held 126 positions worth $118M, down 19% from $145M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

O'Rourke & Company withdrew a net $6.98M in Q2 2022, closing 12 positions and reducing 62 holdings. Its most notable exit was Coinbase, an estimated $510K position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, O'Rourke & Company opened a new position in Vanguard Tax-Exempt Bond Index Fund worth $431K.

  • O'Rourke & Company's largest Q2 2022 buy was Vanguard Tax-Exempt Bond Index Fund: 8,643 shares worth $431K.
  • O'Rourke & Company added most to Vanguard Morningstar Small-Cap Value ETF in Q2 2022, an estimated $253K increase.
  • O'Rourke & Company's biggest Q2 2022 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $1.59M.
  • O'Rourke & Company fully exited Coinbase in Q2 2022, selling an estimated $510K.
  • O'Rourke & Company's ten largest holdings make up 42% of its $118M portfolio in Q2 2022.
  • O'Rourke & Company opened 4 new positions and closed 12 in Q2 2022.
  • O'Rourke & Company's portfolio value fell 19% quarter-over-quarter to $118M.

Based on O'Rourke & Company's 13F filing for Q2 2022, filed 12 Aug 2022.